According to foreign media reports, Johnson & Johnson announced plans last Friday to split its consumer products business from its pharmaceutical and medical device operations, creating two publicly traded companies.

        The separation will sheer off its household products unit, maker of Band-Aid bandages, Aveeno and Neutrogena skin care products, and Listerine, from its riskier, but faster-growing division that makes and sells prescription drugs and medical devices, including its Covid-19 vaccine.

        The company said it hopes to complete the transaction in 18 to 24 months. The pharmaceutical and medical device division, which includes advanced technologies like robotics and artificial intelligence, would retain the name Johnson & Johnson and keep J&J’s incoming CEO, Joaquin Duato, at its helm.

        About Johnson & Johnson

        Johnson & Johnson was established in 1886 and is the world's largest, diversified medical, health care and consumer care product company. Johnson & Johnson's production and sales of products involve many fields such as nursing products, pharmaceutical products, medical equipment and diagnostic products markets. It owns many well-known brands such as Johnson & Johnson, Neutrogena, Smart, Jiaoshuang, Bondi, Daknin, Tylenol etc.

       On the ranking of “The First Daguan·Keweiwei World Brand Value Top 900" released on March 14, 2021, Johnson & Johnson's brand value was 9,097.63 billion RMB, ranking the 11th. 

作者：Nan